|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,589.00 GBX | +0.55% |
|
+0.73% | +30.03% |
| 12-10 | Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in small trial | RE |
| 12-10 | Banks support FTSE 100 ahead of Fed decision | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 14,148 | 14,148 | 13,974 |
| Spread/Res. | -4.48% | -4.48% | -3.29% |
| Spread/Supp. | +1.79% | +9.30% | +14.62% |
| Support | 13,276 | 12,364 | 11,790 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- AZN Stock
- Charts AstraZeneca PLC
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition